US 12,404,238 B2
Psilocybin derivatives
Andrew R. Chadeayne, Issaquah, WA (US)
Assigned to CAAMTECH, INC., Issaquah, WA (US)
Appl. No. 18/717,094
Filed by CAAMTECH, INC., Issaquah, WA (US)
PCT Filed Dec. 12, 2022, PCT No. PCT/US2022/081343
§ 371(c)(1), (2) Date Jun. 6, 2024,
PCT Pub. No. WO2023/108167, PCT Pub. Date Jun. 15, 2023.
Claims priority of provisional application 63/330,473, filed on Apr. 13, 2022.
Claims priority of provisional application 63/314,550, filed on Feb. 28, 2022.
Claims priority of provisional application 63/288,000, filed on Dec. 10, 2021.
Prior Publication US 2024/0417373 A1, Dec. 19, 2024
Int. Cl. C07D 209/14 (2006.01)
CPC C07D 209/14 (2013.01) 8 Claims
 
1. A crystalline form 1 of methanol 5-[(3-{2-[bis(propan-2-yl) azaniumyl]ethyl}-1H-indol-4-yl)oxy]-5-oxopentanoate.